サインイン

Jieyu Xing

School of Pharmaceutical Sciences,
Center for Cellular & Structural Biology

Sun Yat-sen University

BIOGRAPHY

Jieyu Xing has not added Biography.

If you are Jieyu Xing and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

A targeted IL-15 fusion protein with potent anti-tumor activity.

Cancer biology & therapy , 2015 | Pubmed ID: 26176990

A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.

AMB Express Dec, 2016 | Pubmed ID: 27112931

BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells.

Translational oncology Oct, 2017 | Pubmed ID: 28797938

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.

International journal of nanomedicine , 2018 | Pubmed ID: 29881272

INSTITUTIONS

Sun Yat-sen University

JOVE ARTICLES

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Yanlan Wang^1,2,

Jiayu Liu^1,2,

Haitao Pan^1,2,

Jieyu Xing^1,2,

Xiaoqiong Wu^1,2,

Qing Li^1,2,

Zhong Wang^1,2

¹School of Pharmaceutical Sciences, Sun Yat-Sen University,

²Center for Cellular & Structural Biology, Sun Yat-Sen University

Cancer Research

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

Jieyu Xing

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}School of Pharmaceutical Sciences,Center for Cellular & Structural Biology

Sun Yat-sen University

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

School of Pharmaceutical Sciences,
Center for Cellular & Structural Biology